Steady-state kinetic mechanism, stereospecificity, substrate and inhibitor specificity of Enterobacter cloacae nitroreductase

被引:108
作者
Koder, RL
Miller, AF
机构
[1] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1998年 / 1387卷 / 1-2期
基金
美国国家科学基金会;
关键词
nitroreductase; flavoprotein; ping-pong; stereospecificity; bioremediation;
D O I
10.1016/S0167-4838(98)00151-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enterobacter cloacae nitroreductase (NR) is a flavoprotein which catalyzes the pyridine nucleotide-dependent reduction of nitroaromatics. Initial velocity and inhibition studies have been performed which establish unambiguously a ping-pong kinetic mechanism, NADH oxidation proceeds stereospecifically with the transfer of the pro-R hydrogen to the enzyme and the amide moiety of the nicotinamide appears to be the principal mediator of the interaction between NR and NADH. 2,4-Dinitrotoluene is the most efficient oxidizing substrate examined, with a k(cat)/K-M an order of magnitude higher than those of p-nitrobenzoate, FMN, FAD or riboflavin. Dicoumarol is a potent inhibitor competitive vs. NADH with a K-i of 62 nM. Several compounds containing a carboxyl group are also competitive inhibitors vs. NADH. Yonetani-Theorell analysis of dicoumarol and acetate inhibition indicates that their binding is mutually exclusive, which suggests that the two inhibitors bind to the same site on the enzyme. NAD(+) does not exhibit product inhibition and in the absence of an electron acceptor, no isotope exchange between NADH and P-32-NAD(+) could be detected. NR catalyzes the 4-electron reduction of nitrobenzene to hydroxylaminobenzene with no optically detectable net formation of the putative two-electron intermediate nitrosobenzene. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:395 / 405
页数:11
相关论文
共 67 条
[1]   THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .1. PURIFICATION AND PROPERTIES OF A NITROREDUCTASE ENZYME FROM ESCHERICHIA-COLI - A POTENTIAL ENZYME FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) [J].
ANLEZARK, GM ;
MELTON, RG ;
SHERWOOD, RF ;
COLES, B ;
FRIEDLOS, F ;
KNOX, RJ .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) :2289-2295
[2]   BIOACTIVATION OF DINITROBENZAMIDE MUSTARDS BY AN ESCHERICHIA-COLI-B NITROREDUCTASE [J].
ANLEZARK, GM ;
MELTON, RG ;
SHERWOOD, RF ;
WILSON, WR ;
DENNY, WA ;
PALMER, BD ;
KNOX, RJ ;
FRIEDLOS, F ;
WILLIAMS, A .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (05) :609-618
[3]  
Bailey SM, 1996, GENE THER, V3, P1143
[4]   METABOLIC-ACTIVATION OF THE GENOTOXIC ENVIRONMENTAL CONTAMINANTS 2-NITROFLUORANTHENE AND 3-NITROFLUORANTHENE IN VARIANTS OF SALMONELLA-TYPHIMURIUM TA98 [J].
BALL, LM ;
STOCKING, LM ;
KOHAN, MJ ;
WARREN, SH ;
LEWTAS, J .
MUTAGENESIS, 1995, 10 (06) :497-504
[5]  
BELAND FA, 1989, DNA BINDING 1 NITROP, P1
[6]   Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954 [J].
Bridgewater, JA ;
Springer, CJ ;
Knox, RJ ;
Minton, NP ;
Michael, NP ;
Collins, MK .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) :2362-2370
[7]   The bystander effect of the nitroreductase CB 1954 enzyme prodrug system is due to a cell-permeable metabolite [J].
Bridgewater, JA ;
Knox, RJ ;
Pitts, JD ;
Collins, MK ;
Springer, CJ .
HUMAN GENE THERAPY, 1997, 8 (06) :709-717
[8]  
BRYANT C, 1991, J BIOL CHEM, V266, P4119
[9]  
BRYANT C, 1991, J BIOL CHEM, V266, P4126
[10]  
BRYANT CP, 1990, THESIS UCSD SAN DIEG